Sale

Market Analysis

United States Healthcare Advertising Market Size, Analysis: By Product Type: Pharmaceuticals (Small Molecule Drugs) Advertising Market, Biopharmaceuticals Market, Vaccines Market, Over-the-Counter Drugs Market, Others; Market Dynamics: SWOT Analysis, Porter’s Five Forces Analysis; Competitive Landscape; 2024-2032

United States Healthcare Advertising Market Analysis

The United States healthcare advertising market is driven by the growth opportunities offered to several pharmaceutical marketers by online direct-to-consumer drug advertising. On account of this, they have started shifting their promotional spending on digital promotions such as product web sites, online display advertising, and social media campaigns. In addition to this, Google has permitted the advertisement of prescription drugs, addiction services, HIV home tests, and clinical trial recruitment across the country, further aiding the growth of the industry.

 

The industry is further invigorated by the advertisement of the medications, which is done after obtaining the certification permitting the usage of relevant keywords. Moreover, many pharmaceutical companies have begun advertising through different channels like multiple synchronised communication channels to boost their consumer reach. Apart from this, the technological advancement over the years has empowered consumers to find relevant information concerning various health-related conditions and the various available treatments. On account of this, the industry is witnessing an increase and is expected to expand over the forecast period.

 

United States Healthcare Advertising Market Report Snapshots

United States Healthcare Advertising Market Size

United States Healthcare Advertising Market Analysis

United States Healthcare Advertising Companies

 

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.

1    Preface
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    United States Healthcare Advertising Market Snapshot
7    Opportunities and Challenges in the Market

    7.1    What Drives the Healthcare Advertising Market in the US?
        7.1.1    Digitalization and other Technological Advancements
        7.1.2    Increasing Presence of Generic and Me-too Drugs
        7.1.3    Government Regulations Supporting DTC Advertising
        7.1.4    Launch of New Drugs
        7.1.5    Increased Consumer Reach through Mobile Advertising
        7.1.6    Other Key Drivers
    7.2    Market Challenges
        7.2.1    Trust Gap between Consumers and Advertisers
        7.2.2    Strict Rules and Regulations by FDA
        7.2.3    Unethical Practices
        7.2.4    Macroeconomic Scenario
        7.2.5    Other Challenges
8    United States Healthcare Advertising Market Analysis
    8.1    Key Industry Highlights
    8.2    United States Healthcare Advertising Historical Market (2018-2023) 
    8.3    United States Healthcare Advertising Market Forecast (2024-2032)
    8.4    United States Healthcare Advertising Market by Product Type
        8.4.1    Pharmaceuticals (Small Molecule Drugs) Advertising Market
            8.4.1.1    Historical Trend (2018-2023)
            8.4.1.2    Forecast Trend (2024-2032)
            8.4.1.3    Breakup by Advertising Channel
            8.4.1.4    Advertising Spend by Key Players
        8.4.2    Biopharmaceuticals Market
            8.4.2.1    Historical Trend (2018-2023)
            8.4.2.2    Forecast Trend (2024-2032)
            8.4.2.3    Breakup by Advertising Channel
            8.4.2.4    Advertising Spend by Key Players
        8.4.3    Vaccines Market
            8.4.3.1    Historical Trend (2018-2023)
            8.4.3.2    Forecast Trend (2024-2032)
            8.4.3.3    Breakup by Advertising Channel
            8.4.3.4    Advertising Spend by Key Players
        8.4.4    Over-the-Counter Drugs Market
            8.4.4.1    Historical Trend (2018-2023)
            8.4.4.2    Forecast Trend (2024-2032)
            8.4.4.3    Breakup by Advertising Channel
            8.4.4.4    Advertising Spend by Key Players
        8.4.5    Others
9    Current Trends in Healthcare Advertising
    9.1    Focus on Content
    9.2    Rise of Multichannel Marketing
    9.3    Targeting Consumers with Local Advertising
    9.4    Reliance on Social Media
    9.5    Surging Mobile Marketing
    9.6    Consumers Becoming Researchers
    9.7    Information Dispensed through Videos
    9.8    Increasing Importance of Online Reviews 
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
            10.2.1    Supplier’s Power
            10.2.2    Buyers Power
            10.2.3    Threat of New Entrants
            10.2.4    Degree of Rivalry
            10.2.5    Threat of Substitutes
    10.3    Key Indicators for Demand
    10.4    Key Indicators for Price
11    Value Chain Analysis
12    Market Challenges
13    Competitive Landscape

    13.1    Market Structure
    13.2    Company Profiles
        13.2.1    Johnson & Johnson Services, Inc 
            13.2.1.1    Company Overview
            13.2.1.2    Financial Summary
            13.2.1.3    Advertising Spend by Channel
            13.2.1.4    Global Sales and Advertising Spend
            13.2.1.5    Certifications
        13.2.2    Pfizer Inc
            13.2.2.1    Company Overview
            13.2.2.2    Financial Summary
            13.2.2.3    Advertising Spend by Channel
            13.2.2.4    Global Sales and Advertising Spend
            13.2.2.5    Certifications
        13.2.3    Merck & Co., Inc
            13.2.3.1    Company Overview
            13.2.3.2    Financial Summary
            13.2.3.3    Advertising Spend by Channel
            13.2.3.4    Global Sales and Advertising Spend
            13.2.3.5    Certifications
        13.2.4    GlaxoSmithKline plc.
            13.2.4.1    Company Overview
            13.2.4.2    Financial Summary
            13.2.4.3    Advertising Spend by Channel
            13.2.4.4    Global Sales and Advertising Spend
            13.2.4.5    Certifications
        13.2.5    Eli Lilly and Company
            13.2.5.1    Company Overview
            13.2.5.2    Financial Summary
            13.2.5.3    Advertising Spend by Channel
            13.2.5.4    Global Sales and Advertising Spend
            13.2.5.5    Certifications
        13.2.6    Novartis AG
            13.2.6.1    Company Overview
            13.2.6.2    Financial Summary
            13.2.6.3    Advertising Spend by Channel
            13.2.6.4    Global Sales and Advertising Spend
            13.2.6.5    Certifications
        13.2.7    Sanofi-Aventis U.S. LLC
            13.2.7.1    Company Overview
            13.2.7.2    Financial Summary
            13.2.7.3    Advertising Spend by Channel
            13.2.7.4    Global Sales and Advertising Spend
            13.2.7.5    Certifications
        13.2.8    AstraZeneca
            13.2.8.1    Company Overview
            13.2.8.2    Financial Summary
            13.2.8.3    Advertising Spend by Channel
            13.2.8.4    Global Sales and Advertising Spend
            13.2.8.5    Certifications
        13.2.9    F. Hoffmann-La Roche Ltd
            13.2.9.1    Company Overview
            13.2.9.2    Financial Summary
            13.2.9.3    Advertising Spend by Channel
            13.2.9.4    Global Sales and Advertising Spend
            13.2.9.5    Certifications
        13.2.10    Bayer AG
            13.2.10.1    Company Overview
            13.2.10.2    Financial Summary
            13.2.10.3    Advertising Spend by Channel
            13.2.10.4    Global Sales and Advertising Spend
            13.2.10.5    Certifications
        13.2.11    Bristol-Myers Squibb Company
            13.2.11.1    Company Overview
            13.2.11.2    Financial Summary
            13.2.11.3    Advertising Spend by Channel
            13.2.11.4    Global Sales and Advertising Spend
            13.2.11.5    Certifications
        13.2.12    Others
14    Key Trends and Developments in the Market

 

List of Key Figures and Tables

1.    United States Healthcare Advertising Market: Key Industry Highlights, 2018 and 2032
2.    United States Healthcare Advertising Historical Market: Breakup by Product Type (USD Billion), 2018-2023
3.    United States Healthcare Advertising Market Forecast: Breakup by Product Type (USD Billion), 2024-2032
4.    United States Generic Drug Market Structure

Key Questions Answered in the Report

In 2023, the healthcare advertising market in the United States attained a value of nearly USD 22.84 billion.

The market is projected to grow at a CAGR of 4% between 2024 and 2032.

The market is estimated to witness a moderate growth in the forecast period of 2024-2032 to reach around USD 29.11 billion by 2032.

The major drivers of the market are rising advertisements for drugs, growth opportunities offered to several pharmaceutical marketers, and the rising number of health-conscious consumers in the country.

The key trends guiding the growth of the market include the rise of multichannel marketing and targeting consumers with local advertising.

Pharmaceuticals (small molecule drugs) advertising market, biopharmaceuticals market, vaccines market, and over-the-counter drugs market are the various product types in the market.

In the United States, the goal of healthcare advertising is to increase awareness regarding specific health issues and conditions as well as about the availability of procedures and drugs in the country.

The major players in the United States healthcare advertising market are Johnson & Johnson Services, Inc, Pfizer Inc, Merck & Co., Inc, GlaxoSmithKline plc., Eli Lilly and Company, Novartis AG, Sanofi-Aventis U.S. LLC, AstraZeneca, F. Hoffmann-La Roche Ltd, Bayer AG, and Bristol- Myers Squibb Company, among others.

Analyst Review

The United States healthcare advertising market attained a value of USD 22.84 billion in 2023, driven by the rising advertisements of prescription drugs. Aided by the rise of multichannel marketing, the industry is expected to witness a further growth in the forecast period of 2024-2032, growing at a CAGR of 4.00%. The healthcare advertising market in the United States is projected to reach USD 29.11 billion by 2032.

EMR's meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on its types, the pharmaceuticals (small molecule drugs) advertising market accounts for the leading share in the industry. The key players in the above industry include Johnson & Johnson, Pfizer Inc, Merck & Co., Inc, GlaxoSmithKline plc., Eli Lilly and Company, Novartis AG, Sanofi-Aventis U.S. LLC, AstraZeneca, F. Hoffmann-La Roche Ltd, Bayer AG, Bristol- Myers Squibb Company, and others.

EMR's research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with industry insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$ 2199     $1999
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$ 3299     $2999
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update
most popular

Five User License

$ 4399     $3999
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$ 5499     $4999
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER